REALISATION B 2024 LTD

Dissolved London

Manufacture of basic pharmaceutical products

1 employees website.com
Healthcare and wellbeing Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparations +2
R

REALISATION B 2024 LTD

Manufacture of basic pharmaceutical products

Founded 21 Aug 2019 Dissolved London, United Kingdom 1 employees website.com
Healthcare and wellbeing Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparationsWholesale of pharmaceutical goodsSpecialists medical practice activities

Previous Company Names

CELLEN BIOTECH LIMITED 21 Aug 2019 — 23 Oct 2024
Accounts Due 31 May 2025 12 months overdue
Confirmation
Net assets £-959K £749K 2023 year on year
Total assets £64K £46K 2023 year on year
Total Liabilities £1M £794K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 21 Lombard Street London EC3V 9AH

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for REALISATION B 2024 LTD (12168524), a dissolved healthcare and wellbeing company based in London, United Kingdom. Incorporated 21 Aug 2019. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

£36.10k

Increased by £35.76k (+10487%)

Net Assets

-£959.24k

Decreased by £748.68k (-356%)

Total Liabilities

£1.02M

Increased by £794.43k (+347%)

Turnover

N/A

Employees

1

Decreased by 1 (-50%)

Debt Ratio

1596%

Increased by 350 (+28%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Bystrom, Eric GustafDirectorSwedishUnited Kingdom4321 Aug 2019Active

Shareholders

Shareholders (1)

Cellen Life Sciences Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 21 Aug 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

REALISATION B 2024 LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Mar 2026InsolvencyLiquidation In Administration Move To Dissolution
11 Sept 2025InsolvencyLiquidation In Administration Extension Of Period
14 Apr 2025InsolvencyLiquidation In Administration Progress Report
14 Nov 2024InsolvencyLiquidation In Administration Statement Of Affairs With Form Attached
23 Oct 2024Change Of NameCertificate Change Of Name Company
13 Mar 2026 Insolvency

Liquidation In Administration Move To Dissolution

11 Sept 2025 Insolvency

Liquidation In Administration Extension Of Period

14 Apr 2025 Insolvency

Liquidation In Administration Progress Report

14 Nov 2024 Insolvency

Liquidation In Administration Statement Of Affairs With Form Attached

23 Oct 2024 Change Of Name

Certificate Change Of Name Company

Recent Activity

Latest Activity

Liquidation In Administration Move To Dissolution

1 months ago on 13 Mar 2026

Liquidation In Administration Extension Of Period

7 months ago on 11 Sept 2025

Liquidation In Administration Progress Report

1 years ago on 14 Apr 2025

Liquidation In Administration Statement Of Affairs With Form Attached

1 years ago on 14 Nov 2024

Certificate Change Of Name Company

1 years ago on 23 Oct 2024